Navigation Links
Duane Reade Holdings, Inc. Further Strengthens Management Team With Addition of Frank Scorpiniti, SVP, Pharmacy Operations
Date:12/8/2008

NEW YORK, Dec. 8 /PRNewswire/ -- Duane Reade Holdings, Inc. today announced the appointment of Mr. Frank Scorpiniti, 38, as Senior Vice President of Pharmacy Operations effective December 1, 2008. Mr. Scorpiniti reports directly to John Lederer, Chairman and Chief Executive Officer. His appointment adds value and expertise to Duane Reade's capable management team which has recently benefited from the appointments of several other senior executives.

Mr. John Lederer, Chairman and Chief Executive Officer, commented, "We are very pleased to have Frank Scorpiniti join our strong management team as Senior Vice President of Pharmacy Operations. We are confident that Frank's many years of experience in the pharmacy industry and his strong track record in raising customer service standards will help us to significantly improve our pharmacy business and increase the accessibility and availability of our pharmacy offerings."

Mr. Scorpiniti, a 13-year veteran of the pharmacy industry, comes to Duane Reade from Longs Drug Store Corporation, a West Coast regional pharmacy chain store that recently became a wholly-owned subsidiary of CVS Caremark Corporation. Mr. Scorpiniti held positions of increasing responsibility throughout his career at Longs and most recently served as Vice President of Pharmacy Operations, overseeing all aspects of Longs' pharmacy business.

Mr. Scorpiniti received his doctorate of pharmacy from University of the Pacific in Stockton, California.

About Duane Reade

Founded in 1960, Duane Reade is the largest drug store chain in the metropolitan New York City area, offering a wide variety of prescription and over-the-counter drugs, health and beauty care items, cosmetics, greeting cards, photo supplies and photofinishing. As of September 27, 2008, the Company operated 245 stores.

Except for historical information contained herein, the statements in this release and the accompanying discussion on the earnings conference call are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In addition, this document may contain statements, estimates or projections that constitute "forward-looking" statements as defined under U.S. federal securities laws. Forward-looking statements involve known and unknown risks and uncertainties, which may cause the Company's actual results in future periods to differ materially from forecasted or expected results. Those risks include, among other things, the competitive environment in the drug store industry in general and in the New York metropolitan area, the ability to open and operate new stores, the continued efforts by payers and government agencies to reduce prescription reimbursement rates and prescription drug benefits,

the strength of the economy in general, the economic conditions in the New York greater metropolitan area, changes in federal and state laws and regulations, including the potential impact of changes in regulations surrounding the importation of pharmaceuticals from foreign countries and changes in laws governing minimum wage requirements, changes in the Company's operating strategy, capital expenditure plans or development plans, the Company's ability to attract, hire and retain qualified pharmacy and other personnel, the Company's significant indebtedness, labor disturbances, the continued impact of, or new occurrences of, terrorist attacks in the New York greater metropolitan area and any actions that may be taken in response, demographic changes, the Company's ability to limit fraud and shrink, the

results of the Company's legal proceedings and recalls of pharmaceutical products due to health concerns or other reasons. Those and other risks are more fully described in Duane Reade's reports filed with the SEC from time to time, including its annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Except to the extent otherwise required by federal securities laws, we do not undertake to publicly update or revise any forward-looking statements.

     Contact:   Duane Reade Holdings, Inc.
                John Henry
                Chief Financial Officer
                (212) 273-5746

    Investors:  Cara O'Brien/Caren Villarreal
    Press:      Diane Zappas
                (212) 850-5600
                FD


'/>"/>
SOURCE Duane Reade Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Duane Reade Holdings, Inc. Reports Third Quarter Results
2. Duane Reade Goes Pink to Support 2008 Komen New York City Race for the Cure(R)
3. Duane Reade Announces Proud Sponsorship of AIDS Walk New York
4. Duane Reade Holdings, Inc. Announces Resignation of Chief Marketing Officer
5. Duane Reade Holdings, Inc. to Report Fourth Quarter and Full Year 2007 Financial Results
6. Duane Reade Holdings, Inc. to Report Third Quarter 2007 Financial Results
7. Gerstman Family Spotlighted on Readers Digest Website
8. Health Book Summaries Subscriber Base Grows to 60,000 Readers as Health Consumers Applaud Free Format
9. Misys Wins Best Trade Processing Product Accolade in European Banking Technology Readers Choice Awards
10. Winners Selected as Beautiful Warriors by Ford Warriors in Pink and Readers Digest for Exemplifying the Fight Against Breast Cancer
11. Superfast Lightweight Free PDF Reader is Launched by Drumlin Security
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2016)... ... , ... "TransPanel Volume 2 is a package of fading panel transitions that ... of Pixel Film Studios. , TransPanel Volume 2 is a set of fading ... versatile transitions features presets with up to 4 panels with complementary line animations. ...
(Date:12/9/2016)... , ... December 09, 2016 , ... ... assistance from offices in Pasco and Richland, is initiating a charity drive to ... injuries resulting from a recent automobile collision. , On October 29th of ...
(Date:12/9/2016)... ... December 09, 2016 , ... Sober College, the game-changing dual ... opening of the Sober College Robert Pfeifer Memorial Learning Center at its location ... was attended by an overwhelming amount of alumni, family, colleagues and friends of ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... "I had ... an inventor from Winchester, Va. "I thought that if the nebulizer had a more ... rather than fearing them." , He developed the patent-pending NEBY to avoid the need ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported local ... “This was our first franchise-wide Quack Gives Back initiative, and we’re ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Allergy Diagnostics Market: Scope and Methodology ... are used to determine the presence of allergens ... etc. in the samples by determining the presence ... report on global allergy diagnostics market, analyzes the ... report consists of an executive summary that provides ...
(Date:12/8/2016)... 8, 2016 Research and Markets has announced the addition ... their offering. ... This report analyzes the worldwide markets for Endodontic Supplies in US$ ... , Japan , Europe , ... World. Annual estimates and forecasts are provided for the period 2015 ...
(Date:12/8/2016)... de 2016  A Mederi Therapeutics Inc . anunciou aprovação regulatória, pela ... para a doença do refluxo gastroesofágico (DRGE). Foto -  http://photos.prnewswire.com/prnh/20161207/446903 ... ... Live Stretta procedure performed and broadcast during the Chinese Congress of ... , , ...
Breaking Medicine Technology: